Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Biopharma (CBIO) Non Operating Income (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Non Operating Income for 7 consecutive years, with -$2.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income changed N/A to -$2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.8 million, a N/A change, with the full-year FY2025 number at -$690000.0, down 131.94% from a year prior.
  • Non Operating Income was -$2.7 million for Q4 2025 at Crescent Biopharma, down from $610978.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $610978.0 in Q3 2023 to a low of -$2.7 million in Q4 2025.